ArticleBMC cancer2019

Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.

Daniel J Craig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.